Squarepoint’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Buy |
+26,386
| New | +$298K | ﹤0.01% | 2169 |
|
|
2024
Q4 | – | Sell |
-25,749
| Closed | -$298K | – | 3014 |
|
|
2024
Q3 | $298K | Buy |
+25,749
| New | +$298K | ﹤0.01% | 2001 |
|
|
2023
Q2 | – | Sell |
-14,432
| Closed | -$113K | – | 2626 |
|
|
2023
Q1 | $113K | Buy |
+14,432
| New | +$113K | ﹤0.01% | 2001 |
|
|
2021
Q3 | – | Sell |
-8,919
| Closed | -$214K | – | 2500 |
|
|
2021
Q2 | $214K | Sell |
8,919
-14,822
| -62% | -$356K | ﹤0.01% | 2185 |
|
|
2021
Q1 | $610K | Buy |
+23,741
| New | +$610K | ﹤0.01% | 1392 |
|
|
2020
Q3 | – | Sell |
-14,853
| Closed | -$180K | – | 2504 |
|
|
2020
Q2 | $180K | Sell |
14,853
-61,057
| -80% | -$740K | ﹤0.01% | 1781 |
|
|
2020
Q1 | $581K | Sell |
75,910
-47,133
| -38% | -$361K | 0.01% | 959 |
|
|
2019
Q4 | $2.19M | Sell |
123,043
-844
| -0.7% | -$15K | 0.01% | 832 |
|
|
2019
Q3 | $1.44M | Buy |
123,887
+52,643
| +74% | +$611K | 0.01% | 974 |
|
|
2019
Q2 | $1.58M | Buy |
+71,244
| New | +$1.58M | 0.02% | 970 |
|